COVID-19 is devastating the fight against tuberculosis (TB). The world needs to step back up to end TB. For the first time in the Global Fund to Fight AIDS, Tuberculosis, and Malaria’s 20-year history, its recently released annual results report shows a decline in the fight against HIV/AIDS, TB, and malaria, with TB efforts being particularly disrupted. About one million fewer people with TB were treated in 2020 compared to 2019, a tragically significant 18 per cent decrease. The report confirms the urgent need to address the ongoing TB crisis, which was the leading infectious disease killer prior to COVID-19 and still is, even with COVID-19. At a Global Fund board meeting in July, Canada expressed support for an increase in TB funding and in-depth analyses on disease burdens to better reflect the needs of each disease. The Global Fund needs to ensure better, more equitable funding across diseases. As the largest and leading multilateral funder for TB, the Global Fund’s allocation methodology is critical to the fight to end TB. The Global Fund must increase its financing of TB to regain progress lost throughout the COVID-19 pandemic and to meet rapidly approaching TB elimination targets. Despite accounting for the most deaths and having been impacted the worst by COVID-19, TB receives far less money than AIDS and malaria from the Global Fund. Please support an increase in financing for TB and more in-depth analyses on disease burdens; the disease burden of TB is greater than those for AIDS, malaria, or COVID-19. Marnie Shaw Calgary, Alta.